Skip to main content
    T

    Thermo Fisher Scientific Inc (TMO)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $691.77
    -8.45 (-1.21%)

    Market Cap: $259.44B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Thermo Fisher Scientific Inc (TMO) Earnings: Report Dates and Results

    Updated Oct 21, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Thermo Fisher Scientific (TMO) is expected to report earnings on Jan 27, 2027. In the quarter ended Sep 30, 2026, Thermo Fisher Scientific reported EPS of $6.68, above the $6.40 estimate. It beat the EPS estimate in each of the last 13 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    95%(38/40)
    Avg Surprise
    +6.01%
    Streak
    13 Q

    Upcoming Estimates

    Reports Jan 27, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$7.19
    Range$6.86 - $7.62
    23 analysts
    Revenue Consensus
    $12.98B
    Range$12.46B - $13.64B
    24 analysts
    Reports Apr 21, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$6.05
    Range$5.64 - $6.53
    13 analysts
    EPS Revisions
    6
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$6.00+0.8%
    60d ago$6.00+0.8%
    30d ago$5.98+1.2%
    7d ago$6.050.0%
    Current$6.05
    Revenue Consensus
    $11.74B
    Range$11.60B - $11.98B
    11 analysts

    Next Report

    TMO has an expected report date of Jan 27, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 9.4% above the $6.57 reported for the quarter ended Dec 31, 2025.

    TMO Earnings Call

    The latest TMO earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, TMO beat 38, missed 1 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $12.14B, up 9.2% from $11.12B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$6.68$6.40$6.33 - $6.47+4.38%Beat+15.4%222 up, 1 downOct 21, 2026$12.14B
    Jun 30, 2026$6.03$5.71$5.65 - $5.75+5.60%Beat+12.5%212 up, 12 downJul 23, 2026$11.99B
    Mar 31, 2026$5.44$5.24$5.02 - $5.34+3.82%Beat+5.6%194 up, 6 downApr 23, 2026$11.01B
    Dec 31, 2025$6.57$6.45$6.38 - $6.51+1.86%Beat+7.7%211 up, 1 downJan 29, 2026$12.21B
    Sep 30, 2025$5.79$5.50$5.44 - $5.64+5.27%Beat+9.7%203 up, 3 downOct 22, 2025$11.12B
    Jun 30, 2025$5.36$5.23$5.19 - $5.29+2.49%Beat-0.2%213 up, 3 downJul 23, 2025$10.86B
    Mar 31, 2025$5.15$5.10$5.02 - $5.14+0.98%Beat+0.8%222 up, 7 downApr 23, 2025$10.36B
    Dec 31, 2024$6.10$5.94$5.72 - $6.00+2.69%Beat+7.6%212 up, 2 downJan 30, 2025$11.39B
    Sep 30, 2024$5.28$5.25$5.15 - $5.43+0.57%Beat-7.2%231 up, 2 downOct 23, 2024$10.60B
    Jun 30, 2024$5.37$5.12$5.05 - $5.20+4.88%Beat+4.3%204 up, 1 downJul 24, 2024$10.54B
    Mar 31, 2024$5.11$4.71$4.61 - $4.75+8.49%Beat+1.6%203 up, 1 downApr 24, 2024$10.35B
    Dec 31, 2023$5.67$5.64$5.62 - $5.73+0.53%Beat+5.0%201 up, 0 downJan 31, 2024$10.89B
    Sep 30, 2023$5.69$5.61$5.45 - $5.78+1.43%Beat+12.0%211 up, 1 downOct 25, 2023$10.57B
    Jun 30, 2023$5.15$5.43$5.25 - $5.57-5.16%Miss-6.5%222 up, 0 downJul 26, 2023$10.69B
    Mar 31, 2023$5.03$5.03$4.78 - $5.280.00%In line-30.6%222 up, 1 downApr 26, 2023$10.71B
    Dec 31, 2022$5.40$5.20$5.06 - $5.32+3.85%Beat-17.4%211 up, 1 downFeb 1, 2023$11.45B
    Sep 30, 2022$5.08$4.82$4.56 - $5.12+5.39%Beat-11.8%204 up, 1 downOct 26, 2022$10.68B
    Jun 30, 2022$5.51$4.98$4.72 - $5.42+10.64%Beat-1.6%192 up, 1 downJul 28, 2022$10.97B
    Mar 31, 2022$7.25$6.21$5.42 - $6.87+16.75%Beat+0.6%192 up, 1 downApr 28, 2022$11.82B
    Dec 31, 2021$6.54$5.27$4.78 - $7.09+24.10%Beat-7.8%195 up, 0 downFeb 2, 2022$10.70B
    Sep 30, 2021$5.76$4.70$4.45 - $5.10+22.55%Beat+2.3%18N/AOct 27, 2021$9.33B
    Jun 30, 2021$5.60$5.47$4.74 - $5.90+2.38%Beat+44.0%19N/AJul 28, 2021$9.27B
    Mar 31, 2021$7.21$6.68$6.08 - $7.58+7.93%Beat+145.2%19N/AApr 29, 2021$9.91B
    Dec 31, 2020$7.09$6.57$5.79 - $7.43+7.91%Beat+99.7%19N/AFeb 1, 2021$10.55B
    Sep 30, 2020$5.63$4.30$3.45 - $4.85+30.93%Beat+91.5%17N/AOct 21, 2020$8.52B
    Jun 30, 2020$3.89$2.89$1.89 - $3.50+34.60%Beat+28.0%16N/AJul 22, 2020$6.92B
    Mar 31, 2020$2.94$2.82$1.97 - $2.99+4.26%Beat+4.6%15N/AApr 22, 2020$6.23B
    Dec 31, 2019$3.55$3.54$3.51 - $3.60+0.28%Beat+9.2%17N/AJan 30, 2020$6.83B
    Sep 30, 2019$2.94$2.89$2.83 - $3.00+1.73%Beat+12.2%13N/AOct 23, 2019$6.27B
    Jun 30, 2019$3.04$3.00$2.94 - $3.06+1.33%Beat+10.5%15N/AJul 24, 2019$6.32B
    Mar 31, 2019$2.81$2.74$2.68 - $2.76+2.55%Beat+12.4%15N/AApr 24, 2019$6.13B
    Dec 31, 2018$3.25$3.18$3.16 - $3.24+2.20%Beat+16.5%16N/AJan 30, 2019$6.51B
    Sep 30, 2018$2.62$2.56$2.48 - $2.60+2.34%Beat+13.4%15N/AOct 24, 2018$5.92B
    Jun 30, 2018$2.75$2.63$2.60 - $2.66+4.56%Beat+19.6%14N/AJul 25, 2018$6.08B
    Mar 31, 2018$2.50$2.41$2.30 - $2.61+3.73%Beat+20.2%14N/AApr 25, 2018$5.85B
    Dec 31, 2017$2.79$2.67$2.64 - $2.75+4.49%Beat+15.8%14N/AJan 31, 2018$6.05B
    Sep 30, 2017$2.31$2.25$2.18 - $2.30+2.67%Beat+13.8%12N/AOct 25, 2017$5.12B
    Jun 30, 2017$2.30$2.27$2.22 - $2.32+1.32%Beat+13.3%14N/AJul 26, 2017$4.99B
    Mar 31, 2017$2.08$2.02N/A+2.97%Beat+15.6%N/AN/AApr 26, 2017$4.76B
    Dec 31, 2016$2.41$2.38N/A+1.26%Beat+13.7%N/AN/AJan 31, 2017$4.95B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $22.87, up 4.6% from the year before. It was $8.27 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$22.87+4.6%
    Dec 31, 2024$21.86+1.5%
    Dec 31, 2023$21.54-7.3%
    Dec 31, 2022$23.24-7.4%
    Dec 31, 2021$25.11+28.4%
    Dec 31, 2020$19.55+58.4%
    Dec 31, 2019$12.34+11.0%
    Dec 31, 2018$11.12+17.3%
    Dec 31, 2017$9.48+14.6%
    Dec 31, 2016$8.27N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,300 words across 11 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,25011
    2026Q2Jun 30, 20267,69312
    2026Q1Mar 31, 20266,47612
    2025Q4Dec 31, 20258,82710
    2025Q3Sep 30, 20258,84411
    2025Q2Jun 30, 20258,50510
    2025Q1Mar 31, 20258,12610
    2024Q4Dec 31, 20247,72810

    2026Q3 Earnings Call

    Opening remarks

    Rafael Tejada Vice President, Investor Relations Good morning, and thank you for joining us. On the call with me today is Marc Casper, our Chairman and Chief Executive Officer, and Jim Meyer, Senior Vice President and Chief Financial Officer. Please note this call is being webcast live and will be archived on the investors section of our website, thermofisher.com, under the heading News, Events and Presentations, until the next quarterly earnings call. A copy of the press release of our third quarter earnings is available in the investors section of our website under the heading Financials. Before we begin, let me briefly cover our safe harbor statement. Various remarks that we may make about the company's future expectations, plans and prospects constitute forward-looking statements within the meaning of applicable securities laws. Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties, including those discussed in the company's most recent reports on Form 10-K and Form 10-Q under the heading Risk Factors. These forward-looking statements are based on our current expectations and speak only as of the date they are made. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even in the event of new information, future developments, or otherwise. Also, during this call, we will be referring to certain financial measures not prepared in accordance with generally accepted accounting principles, or GAAP. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures is available in the press release of our third quarter earnings, and also in the investors section of our website under the heading Financials. With that, I'll now turn the call over to Marc.

    Marc Casper Chairman and Chief Executive Officer Thank you, Raf. Good morning, everyone, and thanks for joining us today for our third quarter call. As you saw in our press release, we delivered another excellent quarter with outstanding financial performance. We are advancing our proven growth strategy and continuing to strengthen our trusted partner status with customers. Our PPI Business System is enabling outstanding execution across the company. Looking ahead, we are incredibly well-positioned to deliver an excellent 2026 as we continue to drive long-term value creation for all of our stakeholders and build an even brighter future for our company. To start, let me recap the third quarter financial results. Our revenue grew 9% to $12.14 billion. Adjusted operating income grew 15% to $2.97 billion. Adjusted operating margin expanded by 120 basis points to 24.5%. We grew adjusted EPS by 15% to $6.68 per share. Turning to our performance by end market, let me provide some details on how the quarter played out.

    Frequently Asked Questions About TMO

    When is Thermo Fisher Scientific's next earnings date?

    Thermo Fisher Scientific's next earnings report is expected for Jan 27, 2027.

    Did TMO beat earnings estimates last quarter?

    Yes. Thermo Fisher Scientific reported EPS of $6.68 for the quarter ended Sep 30, 2026, above the $6.40 estimate, a 4.38% surprise.

    What EPS do analysts expect from TMO next quarter?

    The consensus EPS estimate for Thermo Fisher Scientific for the quarter ending Dec 31, 2026 is $7.19 from 23 analysts, with estimates from $6.86 to $7.62.

    How often does TMO beat earnings estimates?

    Thermo Fisher Scientific beat the EPS estimate in each of the last 13 quarters, with an average surprise of +3.31%.